Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model

Background and Purpose Asthma is an inflammatory disease that involves airway hyperresponsiveness and remodelling. Flavonoids have been associated to anti-inflammatory and antioxidant activities and may represent a potential therapeutic treatment of asthma. Our aim was to evaluate the effects of the...

ver descrição completa

Detalhes bibliográficos
Autores: Toledo, Alessandra Choqueta, Sakoda, Camila Pivari Pedroso [UNIFESP], Perini, Adenir, Pinheiro, Nathalia Montouro, Magalhaes, Renato Moschella, Grecco, Simone dos Santos [UNIFESP], Tiberio, Iolanda de Fátima Lopes Calvo, Camara, Niels Olsen Saraiva, Martins, Milton de Arruda, Lago, Joao Henrique Ghilardi [UNIFESP], Prado, Carla Máximo [UNIFESP]
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2013
País:Brasil
Recursos:Universidade Federal de São Paulo (UNIFESP)
Repositório:Repositório Institucional da UNIFESP
Idioma:inglês
OAI Identifier:oai:repositorio.unifesp.br:11600/36116
Acesso em linha:https://dx.doi.org/10.1111/bph.12062
https://repositorio.unifesp.br/handle/11600/36116
Access Level:Acceso aberto
Palavra-chave:sakuranetin
Experimental asthma model
Airway remodelling
Cytokines
Oxidative stress
id BR_ac8d4e86e2a6465b9852c8aac38213c3
oai_identifier_str oai:repositorio.unifesp.br:11600/36116
network_acronym_str BR
network_name_str Brasil
repository_id_str
spelling Flavonone treatment reverses airway inflammation and remodelling in an asthma murine modelsakuranetinExperimental asthma modelAirway remodellingCytokinesOxidative stressBackground and Purpose Asthma is an inflammatory disease that involves airway hyperresponsiveness and remodelling. Flavonoids have been associated to anti-inflammatory and antioxidant activities and may represent a potential therapeutic treatment of asthma. Our aim was to evaluate the effects of the sakuranetin treatment in several aspects of experimental asthma model in mice. Experimental Approach Male BALB/c mice received ovalbumin (i.p.) on days 0 and 14, and were challenged with aerolized ovalbumin 1% on days 24, 26 and 28. Ovalbumin-sensitized animals received vehicle (saline and dimethyl sulfoxide, DMSO), sakuranetin (20mg kg1 per mice) or dexamethasone (5mg kg1 per mice) daily beginning from 24th to 29th day. Control group received saline inhalation and nasal drop vehicle. On day 29, we determined the airway hyperresponsiveness, inflammation and remodelling as well as specific IgE antibody. RANTES, IL-5, IL-4, Eotaxin, IL-10, TNF-, IFN- and GMC-SF content in lung homogenate was performed by Bioplex assay, and 8-isoprostane and NF-kB activations were visualized in inflammatory cells by immunohistochemistry. Key Results We have demonstrated that sakuranetin treatment attenuated airway hyperresponsiveness, inflammation and remodelling; and these effects could be attributed to Th2 pro-inflammatory cytokines and oxidative stress reduction as well as control of NF-kB activation. Conclusions and Implications These results highlighted the importance of counteracting oxidative stress by flavonoids in this asthma model and suggest sakuranetin as a potential candidate for studies of treatment of asthma.Univ São Paulo, Sch Med, Dept Med, São Paulo, BrazilUniv São Paulo, Inst Biol, Dept Imunol, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Biol Sci, Diadema, BrazilUniversidade Federal de São Paulo, Diadema, BrazilUniversidade Federal de São Paulo, Dept Biol Sci, Diadema, BrazilUniversidade Federal de São Paulo, Diadema, BrazilWeb of ScienceFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Wiley-BlackwellUniversidade de São Paulo (USP)Universidade Federal de São Paulo (UNIFESP)2016-01-24T14:31:27Z2016-01-24T14:31:27Z2013-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion1736-1749https://dx.doi.org/10.1111/bph.12062British Journal of Pharmacology. Hoboken: Wiley-Blackwell, v. 168, n. 7, p. 1736-1749, 2013.10.1111/bph.120620007-1188https://repositorio.unifesp.br/handle/11600/36116WOS:000316262500016ark:/48912/0013000025rpjengBritish Journal of Pharmacologyinfo:eu-repo/semantics/openAccesshttp://olabout.wiley.com/WileyCDA/Section/id-406071.htmlreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPToledo, Alessandra ChoquetaSakoda, Camila Pivari Pedroso [UNIFESP]Perini, AdenirPinheiro, Nathalia MontouroMagalhaes, Renato MoschellaGrecco, Simone dos Santos [UNIFESP]Tiberio, Iolanda de Fátima Lopes CalvoCamara, Niels Olsen SaraivaMartins, Milton de ArrudaLago, Joao Henrique Ghilardi [UNIFESP]Prado, Carla Máximo [UNIFESP]2021-11-16T16:59:20Zoai:repositorio.unifesp.br:11600/36116Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652021-11-16T16:59:20Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model
title Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model
spellingShingle Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model
Toledo, Alessandra Choqueta
sakuranetin
Experimental asthma model
Airway remodelling
Cytokines
Oxidative stress
title_short Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model
title_full Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model
title_fullStr Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model
title_full_unstemmed Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model
title_sort Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model
dc.creator.none.fl_str_mv Toledo, Alessandra Choqueta
Sakoda, Camila Pivari Pedroso [UNIFESP]
Perini, Adenir
Pinheiro, Nathalia Montouro
Magalhaes, Renato Moschella
Grecco, Simone dos Santos [UNIFESP]
Tiberio, Iolanda de Fátima Lopes Calvo
Camara, Niels Olsen Saraiva
Martins, Milton de Arruda
Lago, Joao Henrique Ghilardi [UNIFESP]
Prado, Carla Máximo [UNIFESP]
author Toledo, Alessandra Choqueta
author_facet Toledo, Alessandra Choqueta
Sakoda, Camila Pivari Pedroso [UNIFESP]
Perini, Adenir
Pinheiro, Nathalia Montouro
Magalhaes, Renato Moschella
Grecco, Simone dos Santos [UNIFESP]
Tiberio, Iolanda de Fátima Lopes Calvo
Camara, Niels Olsen Saraiva
Martins, Milton de Arruda
Lago, Joao Henrique Ghilardi [UNIFESP]
Prado, Carla Máximo [UNIFESP]
author_role author
author2 Sakoda, Camila Pivari Pedroso [UNIFESP]
Perini, Adenir
Pinheiro, Nathalia Montouro
Magalhaes, Renato Moschella
Grecco, Simone dos Santos [UNIFESP]
Tiberio, Iolanda de Fátima Lopes Calvo
Camara, Niels Olsen Saraiva
Martins, Milton de Arruda
Lago, Joao Henrique Ghilardi [UNIFESP]
Prado, Carla Máximo [UNIFESP]
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
dc.subject.por.fl_str_mv sakuranetin
Experimental asthma model
Airway remodelling
Cytokines
Oxidative stress
topic sakuranetin
Experimental asthma model
Airway remodelling
Cytokines
Oxidative stress
description Background and Purpose Asthma is an inflammatory disease that involves airway hyperresponsiveness and remodelling. Flavonoids have been associated to anti-inflammatory and antioxidant activities and may represent a potential therapeutic treatment of asthma. Our aim was to evaluate the effects of the sakuranetin treatment in several aspects of experimental asthma model in mice. Experimental Approach Male BALB/c mice received ovalbumin (i.p.) on days 0 and 14, and were challenged with aerolized ovalbumin 1% on days 24, 26 and 28. Ovalbumin-sensitized animals received vehicle (saline and dimethyl sulfoxide, DMSO), sakuranetin (20mg kg1 per mice) or dexamethasone (5mg kg1 per mice) daily beginning from 24th to 29th day. Control group received saline inhalation and nasal drop vehicle. On day 29, we determined the airway hyperresponsiveness, inflammation and remodelling as well as specific IgE antibody. RANTES, IL-5, IL-4, Eotaxin, IL-10, TNF-, IFN- and GMC-SF content in lung homogenate was performed by Bioplex assay, and 8-isoprostane and NF-kB activations were visualized in inflammatory cells by immunohistochemistry. Key Results We have demonstrated that sakuranetin treatment attenuated airway hyperresponsiveness, inflammation and remodelling; and these effects could be attributed to Th2 pro-inflammatory cytokines and oxidative stress reduction as well as control of NF-kB activation. Conclusions and Implications These results highlighted the importance of counteracting oxidative stress by flavonoids in this asthma model and suggest sakuranetin as a potential candidate for studies of treatment of asthma.
publishDate 2013
dc.date.none.fl_str_mv 2013-04-01
2016-01-24T14:31:27Z
2016-01-24T14:31:27Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://dx.doi.org/10.1111/bph.12062
British Journal of Pharmacology. Hoboken: Wiley-Blackwell, v. 168, n. 7, p. 1736-1749, 2013.
10.1111/bph.12062
0007-1188
https://repositorio.unifesp.br/handle/11600/36116
WOS:000316262500016
dc.identifier.dark.fl_str_mv ark:/48912/0013000025rpj
url https://dx.doi.org/10.1111/bph.12062
https://repositorio.unifesp.br/handle/11600/36116
identifier_str_mv British Journal of Pharmacology. Hoboken: Wiley-Blackwell, v. 168, n. 7, p. 1736-1749, 2013.
10.1111/bph.12062
0007-1188
WOS:000316262500016
ark:/48912/0013000025rpj
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv British Journal of Pharmacology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
http://olabout.wiley.com/WileyCDA/Section/id-406071.html
eu_rights_str_mv openAccess
rights_invalid_str_mv http://olabout.wiley.com/WileyCDA/Section/id-406071.html
dc.format.none.fl_str_mv 1736-1749
dc.publisher.none.fl_str_mv Wiley-Blackwell
publisher.none.fl_str_mv Wiley-Blackwell
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1853670541319208960
score 15,300719